Displaying items 25-36 of 1624
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-136
•
Next >
-
XenoPort to drop multiple sclerosis drug, shares fall
Reuters(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...Tags: Trials, Multiple Sclerosis, Stock Market, Acorda Therapeutics Incorporated, Conservation
-
Senate committee advances drug compounding bill
ReutersNEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines. The proposed legislation was introduced in response to...Tags: Tom Harkin, Meningitis, Politics, U.S. Senate, Drugs and Medicines
-
READER SUBMITTED: Connecticut's First Robotic-Assisted Single Site Hysterectomy
HartfordA surgical team at Hartford Hospital performed the state's and New England's first da Vinci - or robotic-assisted single site hysterectomy on May 2. The patient's uterus was removed through one tiny incision in the belly button, making the procedure...Tags: Hartford Hospital, Hysterectomy, Hospitals and Clinics, Women's Health
-
Doctors save Ohio boy by 'printing' an airway tube
In a medical first, doctors used plastic particles and a 3-D laser printer to create an airway splint to save the life of a baby boy who used to stop breathing nearly every day. It's the latest advance from the booming field of regenerative medicine,...Tags: Healthcare Provider, Ear, Nose, and Throat, Hospitals and Clinics, Human Body, Science and Technology
-
Merck's insomnia drug moves a step closer to U.S. approval
ReutersWASHINGTON (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses. The advisory panel was convened to help the U.S. Food and Drug...Tags: Insomnia, Merck & Company Incorporated, Trials, Politics, Stanford University
-
Do diet changes help ADHD children?
Dylan Jerrell was having a tough time in kindergarten. The energetic, outgoing Bigfoot fan was easily frustrated, and he responded to challenges with disruptive meltdowns. He wouldn't hit anyone, but he'd break down and cry or yell at his teachers....
Tags: Social Sciences, Behavioral Conditions, Pharmaceuticals, Science, Newspaper and Magazine
-
FDA panel favors Merck sleeping aid despite safety concerns over drowsiness, driving issues
AP Health WriterWASHINGTON (AP) — A federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. A...Tags: Insomnia, Merck & Company Incorporated, Politics, Ambien (drug), Washington, DC
-
FDA panel backs a new sleep drug
An advisory panel to the Food & Drug Administration has recommended approval of a new sleep drug that targets the brain's wakefulness centers, but suggested the agency should consider a dose of the drug, called suvorexant, lower than that proposed by...
Tags: Insomnia, Merck & Company Incorporated, Chemical Industry, Pharmaceuticals, Trials
-
In debate over 'biosimilars,' patient safety must come first
In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse. Eventually, I was diagnosed with autoimmune hepatitis,...Tags: Rheumatoid Arthritis, Allergies, Rockville (Bethlehem, Pennsylvania), Health and Medical Professionals, Hepatitis
-
Consumer watchdog: most sunscreens meet FDA standards, but questionable SPF ratings persist
AP Health WriterWASHINGTON (AP) — Sunbathers headed to the beach this summer will find new sunscreen labels on store shelves that are designed to make the products more effective and easier to use. But despite those long-awaited changes, many sunscreens continue to...Tags: Medical Specialization, Dermatologists, Sunburn, Johnson & Johnson Inc., Skin Cancer
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Merck & Company Incorporated, Chemotherapy, Amgen Inc., Roche Holding AG, Medical Research
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Merck & Company Incorporated, Chemotherapy, Amgen Inc., Roche Holding AG, Medical Research
May 20, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Hartford Courant
May 22, 2013
|Story| AP Broadcast
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Chicago Tribune
May 22, 2013
|Story| AP Broadcast
May 22, 2013
|Story| Los Angeles Times
May 22, 2013
|Story| Baltimore Sun
May 20, 2013
|Story| AP Broadcast
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for Food and Drug Administration topic gallery.